Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs
Recruiting
Observational Study
Osteonecrosis of the Jaw
Osteonecrosis Due to Drugs, Jaw
Osteonecrosis Due to Drug
Bisphosphonate-Associated Osteonecrosis
Bisphosphonate-Associated Osteonecrosis of the Jaw
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 126 (estimated)
- Sponsor
- Catholic University of the Sacred Heart · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of this prospective observational study is to investigate the incidence of Medication Related Osteonecrosis of the Jaws (MRONJ) in patients receiving antiresorptive drugs for oncohematologic reasons during a 5-year follow-up. Secondary objectives are to compare the different antiresorptive drugs in relation to the incidence of MRONJ and to identify any systemic as well as local risk …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with specific prescription to initiate therapy with antiresorptive drugs
Exclusion Criteria:
* Previous Head and Neck Radiotherapy
Contacts